Actinium Pharmaceuticals, Inc.
ATNMNYSEPharmaceutical PreparationsUS미국
30일 공시 수
4건
최근 2026.10.16
90일 내부자 순매수
0원
변동 없음
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 12건
- US미국임원·주요주주 소유중요도 낮음2026.10.164 · Statement of changes in beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 4 · 2026.10.16
- US미국임원·주요주주 소유중요도 낮음2026.10.163 · Initial statement of beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 3 · 2026.10.16
- US미국지배구조·주총중요도 보통2026.10.16DEF 14A · Definitive proxy statement
Actinium Pharmaceuticals, Inc.ATNM
DEF 14A · 2026.10.16 20:42 KST
- US미국지배구조·주총중요도 보통2026.10.168-K · Current report (Items 5.02, 7.01, 9.01)
Actinium Pharmaceuticals, Inc.ATNM
8-K · 2026.10.16 06:05 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.103 · Initial statement of beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 3 · 2026.09.10
- US미국임원·주요주주 소유중요도 낮음2026.09.103 · Initial statement of beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 3 · 2026.09.10
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 4 · 2026.09.04
- US미국임원·주요주주 소유중요도 낮음2026.09.044 · Statement of changes in beneficial ownership
Actinium Pharmaceuticals, Inc.ATNM
Form 4 · 2026.09.04